Patents by Inventor Dan Longo

Dan Longo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods and compositions for the treatment and prevention of cancer
    Patent number: 10077296
    Abstract: The instant invention provides compositions for the treatment of cancer. Specifically, the invention provides polypeptides and nucleic acid molecules comprising tumor-associated embryonic antigens, e.g., OFA-iLRP, and chemoattractant ligands, e.g., a proinflammatory chemokine such as MIP3?/CCL20 or ?-defensin mDF2?. The invention further provides cancer vaccines and methods for treating subjects having, or at risk of developing, cancer.
    Type: Grant
    Filed: August 16, 2012
    Date of Patent: September 18, 2018
    Assignee: The United States of America, as represented by the Secretary, Department of Health & Human Services
    Inventors: Bira Arya, Dan Longo, Igor Espinoza-Delgardo
  • METHODS AND COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF CANCER
    Publication number: 20120328640
    Abstract: The instant invention provides compositions for the treatment of cancer. Specifically, the invention provides polypeptides and nucleic acid molecules comprising tumor-associated embryonic antigens, e.g., OFA-iLRP, and chemoattractant ligands, e.g., a proinflammatory chemokine such as MIP3?/CCL20 or ?-defensin mDF2?. The invention further provides cancer vaccines and methods for treating subjects having, or at risk of developing, cancer.
    Type: Application
    Filed: August 16, 2012
    Publication date: December 27, 2012
    Applicant: The Government of the USA, as represented by the Secretary, Department of Health & Human Services
    Inventors: Bira Arya, Dan Longo, Igor Espinoza
  • Methods and compositions for the treatment and prevention of cancer
    Patent number: 8258278
    Abstract: The instant invention provides compositions for the treatment of cancer. Specifically, the invention provides polypeptides and nucleic acid molecules comprising tumor-associated embryonic antigens, e.g., OFA-iLRP, and chemoattractant ligands, e.g., a proinflammatory chemokine such as MIP3?/CCL20 or ?-defensin mDF2?. The invention further provides cancer vaccines and methods for treating subjects having, or at risk of developing, cancer.
    Type: Grant
    Filed: September 3, 2007
    Date of Patent: September 4, 2012
    Assignee: The United States of America, as represented by the Secretary, Department of Health and Human Services
    Inventors: Bira Arya, Dan Longo, Igor Espinoza
  • Methods and compositions for the treatment and prevention of cancer
    Publication number: 20090068234
    Abstract: The instant invention provides compositions for the treatment of cancer. Specifically, the invention provides polypeptides and nucleic acid molecules comprising tumor-associated embryonic antigens, e.g., OFA-iLRP, and chemoattractant ligands, e.g., a proinflammatory chemokine such as MIP3?/CCL20 or ?-defensin mDF2?. The invention further provides cancer vaccines and methods for treating subjects having, or at risk of developing, cancer.
    Type: Application
    Filed: September 3, 2007
    Publication date: March 12, 2009
    Applicant: Government of the US, as represented by the Secretary, Department of Health and Human Services
    Inventors: Arya Biragyn, Dan Longo, Igor Espinoza-Delgado
  • Methods of screening for cell proliferation or neoplastic disorders
    Publication number: 20060003359
    Abstract: The invention relates to methods and compositions for identifying subjects having, or predisposed to having, a neoplastic or cell proliferation or neoplastic disorder. The methods are applicable to any type of tissue sample and can be conducted on otherwise normal tissue.
    Type: Application
    Filed: June 3, 2005
    Publication date: January 5, 2006
    Applicants: THE JOHNS HOPKINS UNIVERSITY, NATIONAL INSTITUTES OF HEALTH
    Inventors: Andrew Feinberg, Christine Iacobuzio-Donahue, Dan Longo, Minoru Ko